AAP updates HPV vaccine recommendations after licensure of HPV9

The recently licensed 9-valent human papillomavirus (HPV9) vaccine is one of three HPV vaccines now recommended by the Academy. The Food and Drug Administration approved HPV9 (Gardasil 9, Merck & Co. Inc.) in December 2014 for use in females ages 9 through 26 years and males ages 9 through 15 years